HLB Life Science to Issue Convertible Bonds
HLB생명과학
067630
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=2547
Risk-adjusted indicator based on 2547 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Total CB amount: 10,000,000,000 KRW
- • Early redemption rate (1st): 110.4486%
- • Early redemption rate (final): 126.6209%
- • Early redemption start date: June 8, 2028
AI Analysis Summary
HLB Life Science CO.,LTD. has decided to issue convertible bonds totaling 10,000,000,000 KRW. The bonds include early redemption options, with rates ranging from 110.4486% (June 8, 2028) to 126.6209% (March 8, 2031). The company will provide collateral, including land and buildings, for the bonds. The issuance could lead to future share dilution, negatively impacting existing shareholders.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.